Display Options:
Total: 1404
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Mucin-1 other
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell
Leukocyte antigen CD37 binding agent
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; HIV Infections; Melanoma; Neoplasms; Ovarian Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung
Programmed cell death protein 1 inhibitor
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse
CD22 binding agent
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Interleukin 17A inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
CD44 antigen binding agent
Antibody
Investigational
Unknown
Unknown
Hypercholesterolemia; Neoplasms; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type II
Subtilisin/kexin type 9 inhibitor
Antibody
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Nasopharyngeal Neoplasms; Small Cell Lung Carcinoma
Epidermal growth factor receptor erbB1 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Tumor necrosis factor receptor superfamily member 10B agonist
Antibody
Investigational
Unknown
Unknown
Glioblastoma; Myelodysplastic Syndromes; Primary Myelofibrosis
Ephrin type-A receptor 3 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Unknown
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Pancreatic Neoplasms
Frizzled-1 antagonist
Antibody
Unknown
Unknown
Unknown
Carcinoma, Squamous Cell
Unknown
Antibody
Investigational
Unknown
Unknown
Central Nervous System Neoplasms
Elongation factor 2 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Tumor necrosis factor receptor superfamily member 12A agonist
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma; Multiple Myeloma; Neoplasms; Myelodysplastic Syndromes
Unknown
Antibody
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
Unknown
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid
Myeloid cell surface antigen CD33 binding agent
Antibody
Investigational
Unknown
Unknown
Autoimmune Diseases; Immunoglobulin G4-Related Disease; Pemphigus; Anemia, Hemolytic, Autoimmune; Myasthenia Gravis
IgG receptor FcRn large subunit p51 antagonist
Antibody
Investigational
Unknown
Unknown
Arthritis, Psoriatic
Interleukin 17A inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Basigin inhibitor
Antibody
Investigational
Unknown
Unknown
Leukemia; Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell
Immunoglobulin epsilon Fc receptor antagonist
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms
Tumor-associated antigen 72 binding agent
Antibody
Unknown
Unknown
Unknown
Neoplasms
Unknown
Antibody
Unknown
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
Antibody
Investigational
Unknown
Unknown
Osteoarthritis, Knee
Beta-nerve growth factor inhibitor